ARCHIVES

PDX Shows 27% Response In T-Cell Lymphoma In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

ORI Says COMS Study Coordinator Committed Scientific Misconduct

April 12, 1996

NCCN Updates Breast Cancer Guidelines for Patients

October 31, 2003

CCOP Application Now Total 180 Plus

November 26, 1982

Senate Committee Adds $100 Million for Cancer, Earmarks Extra Positions for NCI, Backs New Construction

September 19, 1975

Cancer Panel: Lack Of Genetic Basis For Race Presents Dilemma For Studies; Data Collection Must Include Socioeconomic Measures, Report To Clinton Says

March 20, 1998